The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshida, Y.
Right arrow Articles by Cooper, K. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshida, Y.
Right arrow Articles by Cooper, K. D.
The Journal of Immunology, 1998, 161: 5873-5879.
Copyright © 1998 by The American Association of Immunologists

Monocyte Induction of IL-10 and Down-Regulation of IL-12 by iC3b Deposited in Ultraviolet-Exposed Human Skin1

Yuichi Yoshida*,{ddagger}, Kefei Kang2,*, Melvin Berger{dagger}, Guofen Chen*, Anita C. Gilliam*, Autumn Moser*, Ling Wu*, Craig Hammerberg* and Kevin D. Cooper*

* Departments of Dermatology and {dagger} Pediatrics, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, OH 44106; {ddagger} Department of Dermatology, Kyushu University, Fukuoka, Japan; and § Veterans Administration Medical Center, Cleveland, OH 44106


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
CD11b+ monocytic/macrophagic cells (Mo/Mph), which infiltrate into skin after UV irradiation, play an important role in UV-induced immunosuppression. Because in mice, blockade of CD11b (iC3b receptor) on monocytes and depletion of its ligand, iC3b, reverses UV-induced immunosuppression, we asked whether iC3b is deposited in human skin after UV, and whether iC3b can modulate the cytokine profile of Mo/Mph. Immunofluorescence studies revealed that iC3b was newly deposited in UV-exposed skin and was localized in apposition to infiltrating CD11b+ Mo/Mph. In addition, in situ hybridization studies showed that TNF-{alpha} mRNA was also induced in a similar microanatomic localization. To model the effects of these complex signals on infiltrating Mo/Mph following UV exposure, we then tested the effects of immobilized iC3b and TNF-{alpha} on resting blood monocytes. Both IL-10 mRNA synthesis and protein secretion were significantly induced by binding of iC3b in vitro and were synergistically increased by the presence of TNF-{alpha}. The effect was abrogated by a blocking Ab to CD11b, indicating CD11b-iC3b interaction. In contrast, iC3b binding resulted in suppression of IL-12 p40 mRNA and significantly inhibited the production of IL-12 p70 protein. Our studies thus define a novel mechanism for induction of tissue Mo/Mph into an IL-10high/IL-12low state via iC3b in combination with TNF-{alpha}.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Ultraviolet irradiation is known to induce immunosuppression, which has been shown to play a substantial role in the development of skin cancer in humans (1, 2). Although several mechanisms are involved in the UV-induced abrogation of immune responses, modulation of soluble mediators and immunoregulatory cytokines may be an important factor. A role for IL-10 in UV-mediated immunosuppression has been demonstrated in a number of models, such as contact hypersensitivity and delayed-type hypersensitivity (3, 4, 5, 6). IL-10 inhibits Ag-specific Th1 cell proliferation via decreased APC function at the site of UV exposure (7) as well as at distant sites (8) by interfering with up-regulation of costimulatory molecules (9, 10) and suppressing the production of immunostimulatory cytokines, such as IL-12 (11). On the other hand, neutralization of IL-12 prevents contact hypersensitivity and induces hapten-specific tolerance (12). Furthermore, administration of IL-12 prevents UV-induced immunosuppression and overcomes UV-induced tolerance (13, 14).

We previously have shown that CD11b+ monocytic/macrophagic cells (Mo/Mph)3 infiltrating into UV-irradiated skin (15, 16) are responsible for immunosuppression and tolerance induction in mice after UV irradiation (17, 18, 19). In addition, we have reported that CD11b+ Mo/Mph are the major source of IL-10 in UV-exposed human skin compared with keratinocytes (20, 21). However, the mechanism of IL-10 induction by CD11b+ Mo/Mph is not known. UV-induced Mo/Mph express high levels of CD11b (CR3), a ß2 integrin containing an {alpha}-subunit with a binding motif in the I domain for iC3b, ICAM-1, and fibrinogen (22, 23). We hypothesized that interaction of CD11b with its ligand might regulate IL-10 production. Resting blood CD11b+ monocytes produce only low or undetectable levels of IL-10, but produce high levels of IL-10 in vivo after migration from the microvasculature into UV-exposed skin (21). We focused our attention on iC3b, as a potential ligand for CD11b, because we have reported recently that blockade of CD11b and depletion of C3 in UV-exposed murine skin reversed UV-induced immunosuppression, indicating that complement is implicated in locally inducible UV immunosuppression (18, 24). However, it has not been shown whether, where, and when iC3b appears in UV-exposed human skin. Keratinocytes are regarded as the most likely local source of C3 in the skin (25), and complement regulatory proteins can be found in human skin (26). Moreover, deposits of the C3 cleavage fragment C3d, g were shown at the dermal-epidermal junction (DEJ) of normal skin (27), were up-regulated in inflammatory diseases (28), and were observed in keratinocytes of UV-irradiated skin (29), suggesting that this process accompanies skin inflammation. Therefore, if iC3b is produced in UV-exposed skin, binding of iC3b to ß2 integrin on Mo/Mph could affect the production of immunoregulatory cytokines, such as IL-10 and IL-12, in the post-UV milieu. Indeed, recent studies have shown that signaling via CR3 plays an important role in regulating the production of IL-12 (30, 31).

Another key element that may be induced after UV exposure and implicated in UV-induced immunosuppression is TNF-{alpha} (32, 33). For instance, it has been well documented that TNF-{alpha} can be induced by keratinocytes and dermal mast cells after UV irradiation (34, 35) and is known to induce IL-10 in human monocytes in vitro (36). Nevertheless, the localization of TNF-{alpha} mRNA under in vivo conditions has not yet been shown, particularly in relation to iC3b and Mo/Mph localization.

In this study we demonstrate that iC3b deposits and TNF-{alpha} mRNA are induced in UV-exposed skin. Furthermore, we make the novel finding that in vitro binding of iC3b to ß2 integrin on monocytes up-regulates the production of IL-10; conversely, iC3b down-regulates IL-12. IL-10, but not IL-12, production is enhanced by the addition of TNF-{alpha}. This model of the UV-induced microenvironment recapitulates the cytokine profile of in vivo UV-induced Mo/Mph, which are IL-10high/IL-12low, and provides insight into mechanisms of UV-induced immunomodulation and monocyte-macrophage differentiation in inflamed tissues.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Subjects

Adult volunteers participated in this study after institutional review board approval of the protocol and informed consent. Punch biopsies were taken from buttock skin after four minimal erythema doses of UVB irradiation from Westinghouse FS20 bulbs (PSC Lamps, Pittsford, NY) at different time points.

Immunofluorescence microscopy studies

Six-micron frozen sections of biopsies of normal and UVB-irradiated skin were blocked with 10% goat serum/PBS and treated with primary mouse mAb for human iC3b (IgG2b, Quidel, San Diego, CA) or its isotype control IgG2b (Sigma, St. Louis, MO), diluted to 2 µg/ml in 10% goat serum/PBS for 1 h, followed by FITC-conjugated goat anti-mouse IgG2b secondary Ab (Caltag, San Francisco, CA). Double-immunofluorescence staining was performed using additional primary mouse mAb for human CD11b (BEAR 1, IgG1, Immunotech, Westbrook, ME), diluted to 2 µg/ml in 10% goat serum/PBS for 1 h, followed by biotin-conjugated goat anti-mouse IgG1 secondary Ab (Caltag) and rhodamine RedX-conjugated avidin (Molecular Probes, Eugene, OR). Slides were viewed and photographed by fluorescence microscopy (Axiophot, Carl Zeiss, Thornwood, NY).

In situ hybridization

In situ hybridization was performed as previously described (21, 37) with some modifications. Briefly, sections were cut, thaw-mounted on RNase-free poly-L-lysine-coated slides (Sigma), fixed in 4% paraformaldehyde/PBS, dehydrated in an ethanol series, and stored at -80°C. Slides were thawed, treated with proteinase K (Boehringer Mannheim, Indianapolis, IL), and prehybridized for 1–3 h at 42°C. Hybridization was performed overnight at 55°C by adding 1 µg/ml heat-denatured digoxigenin-labeled riboprobe (antisense or control sense). Sections were treated with 100 µg/ml RNase A and 1 µg/ml RNase T1 (both from Boehringer Mannheim) in 2x SSC (Research Genetics, Huntsville, AL) before incubation with alkaline phosphatase-conjugated Abs to digoxigenin and were detected as described previously (21).

cDNA for murine TNF-{alpha} in pGEM transcription vector was used to generate riboprobes for in situ hybridization. Mouse TNF-{alpha} cDNA representing the 700-bp fragment of TNF-{alpha}-coding sequence was a gift from Dr. Bruce Beutler (University of Texas Southwestern Medical School, Dallas, TX). The plasmid was linearized with the appropriate restriction enzymes and was transcribed with SP6 or T7 polymerase in the presence of digoxigenin UTP (Genius kit 4, Boehringer Mannheim) to generate digoxigenin-labeled control sense and antisense RNA probes.

Isolation of human blood monocytes

PBMC were obtained by centrifugation of heparinized fresh peripheral blood with Ficoll gradients (1.077; Sigma). After the incubation of PBMC in tissue culture dishes for 1 h at 37°C, adherent cells were harvested by 0.5 mM EDTA in HBSS (Life Technologies, Grand Island, NY). Cells were treated with blocking Ab (Fc{gamma} RII, anti-CD32) for 10 min on ice and incubated with Ab mixture (anti-CD2, -3, -19, and -56 and glycophorin A) for 15 min and with dextran-iron for 15 min (all from StemCell Technologies, Vancouver, Canada), followed by adherence to a MACS separation column against a MidiMACS magnet (Miltenyi Biotec, Auburn, CA). The purity of negatively selected monocytes, as determined by flow cytometry, was >90%.

Preparation of IgM- and iC3b-coated sheep erythrocytes

IgM-coated sheep erythrocytes (EA) and IgM- plus iC3b-coated sheep erythrocytes (EAiC3b) were prepared as previously described (22, 38) with some modifications. Briefly, EA were generated by incubating erythrocytes with anti-sheep erythrocyte IgM (produced by clone M1/81 · 27 · 7 from American Type Culture Collection, Manassas, VA) for 15 min at 30°C. Then C3b-coated EA was prepared by incubation of EA with C5-deficient human serum (Sigma) for 1 h at 37°C while rotating. The C3b was converted to iC3b by incubation with 1% fresh human serum for 1 h at 37°C. It has been reported that most of the C3b is converted to iC3b, and very little, if any, is degraded further to C3d using this method (38). The presence of iC3b on erythrocytes was verified by flow cytometry using anti-human iC3b or its isotype control IgG2b, followed by FITC-conjugated goat anti-human IgG2b. The expression of iC3b on EAiC3b was about 50-fold increased in fluorescence intensity relative to EA.

Determination of cytokine production by peripheral blood monocytes in response to iC3b

Purified monocytes were plated in six-well tissue culture dishes (1.5–2.0 x 106/well) and incubated with medium alone (RPMI 1640 (Life Technologies) plus 10% FBS (HyClone, Logan, UT)), EA, or EAiC3b (erythrocyte:monocyte ratio of 25:1) for 1 h. Human rTNF-{alpha} (50 ng/ml; R&D Systems, Minneapolis, MA) and/or 0.001% Pansorbin cells (Staphylococcus aureus cells (SAC); Calbiochem-Novabiochem, La Jolla, CA) (39) were added in some wells and were incubated for 20 h at 37°C. In some experiments, for blocking of iC3b binding to CD11b, monocytes were treated with 25 µg/ml M1/70 Ab or its isotype control (IgG2b; both from PharMingen, San Diego, CA) for 1 h before the incubation of EA or EAC. Culture supernatants were harvested and stored at -70°C until assayed, and pellets were subjected to RNA extraction.

RNA extraction and RT-PCR

RT-PCR was performed as previously described (20). Simply, monocyte RNA was extracted by RNeasy Total RNA Kits (Qiagen, Chatsworth, CA) and quantified by spectrophotometric measurement. cDNA was synthesized from 200 ng of total RNA. The primers used for amplification were as follows: human IL-10 (nucleotides 323–347 of the sense strand (5'-CTGAGAACCAAGACCCAGACATCAA-3') and nucleotides 648–674 of the antisense strand (5'-CAATAAGGTTTCTCAAGGGGCTGGGTC-3'); 352 bp), IL-12 p40 (nucleotides 806–822 of the sense strand (5'-CCACATTCCTACTTCTC-3') and nucleotides 1061–1077 of the antisense strand (5'-GTCTATTCCGTTGTGTC-3'); 272 bp), and ß-actin (447 bp). Thirty-two cycles were conducted in QuarterBath Thermal Cycler (Inotech, Lansing, MI) with denaturation at 94°C for 1 min, annealing at 55°C (60°C for ß-actin) for 1 min, and extension at 72°C for 2 min. PCR products were analyzed by electrophoresis with 1.5% agarose gel with ethidium bromide.

Quantification of protein by ELISA

Culture supernatants were assayed by ELISA using mAb pairs of rat anti-human IL-10 (JES3-9D7, IgG1) and biotin-conjugated rat anti-human IL-10 (JES3-12G8, IgG2a; both from PharMingen) for IL-10, and mouse anti-human IL-12 p70 (IgG) and biotin-conjugated mouse anti-human IL-12 (C8.6, IgG; both from Endogen, Cambridge, MA) for IL-12. Human rIL-10 (PharMingen) and rIL-12 (R&D Systems) were used as standards, respectively. Results are expressed as picograms per milliliter.

Statistical analysis

Statistical significance of differences was determined by Student’s t test where indicated.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
UV exposure of human skin causes iC3b deposition in contiguity with infiltrating Mo/Mph

We initiated immunofluorescence studies to investigate alteration of iC3b production and Mo/Mph infiltration after UV exposure in vivo (n = 3). Non-UV control skin and skin taken 6, 24, 48, and 72 h after UV exposure were first stained with isotype control (Fig. 1Goa) or mAb specific for iC3b (Fig. 1Go, b–f). Control skin and skin taken 6 h after UV exposure showed very few iC3b deposits at the DEJ (Fig. 1Go, b and c, white arrows), whereas marked fine granular iC3b deposits were induced in the DEJ of UV-exposed skin taken at 24, 48, and 72 h (Fig. 1Go, d–f). In addition, iC3b+ UV-damaged keratinocytes were identified after UV exposure (Fig. 1Go, e and f, asterisks).



View larger version (68K):
[in this window]
[in a new window]
 
FIGURE 1. iC3b is up-regulated in human skin after UV exposure. Isotype control at 24 h (a), normal skin (b), and skin taken 6 h (c), 24 h (d), 48 h (e), and 72 h (f) after UV exposure were stained with isotype control (a) or anti-iC3b mAb (b–f). White arrowheads show the DEJ (a–c). White arrows show iC3b deposits at the DEJ (b–f), and asterisks show iC3b+ keratinocytes (e and f). Scale bar = 20 µm. n = 3.

 
We next examined whether the iC3b deposits were colocalized in time and space with Mo/Mph that infiltrated UV-exposed skin. We used double staining for iC3b (FITC, green) and CD11b (rhodamine, red; Fig. 2Go, a and c; Fig. 2Gob is the isotype control). There were small numbers of CD11b+ cells in control dermal skin (Fig. 2Goa, white arrowhead). In contrast, UV-exposed skin taken at 48 h (Fig. 2Goc) revealed CD11b+ cells to be increased markedly in the dermis; these cells were regularly observed to be in physical apposition with the fine granular deposits of iC3b along the DEJ (Fig. 2Goc, white arrows). In addition, CD11b+ cells that had migrated into the epidermis were in close contact with epidermal iC3b+ keratinocytes. Although some of the CD11b+ cells were neutrophils, it was confirmed that mononuclear cells were the dominant leukocyte in UV-exposed skin using hematoxylin eosin-stained sections (data not shown). No staining was observed in UV-exposed skin treated with isotype control (Figs. 1Goa and 2b).



View larger version (78K):
[in this window]
[in a new window]
 
FIGURE 2. CD11b+ Mo/Mph infiltrate UV-exposed skin in contiguity with iC3b. Double staining was performed in normal skin (a) and skin taken 48 h after UV exposure (b andc) to mAb anti-iC3b (green color with FITC) and anti-CD11b (red color with rhodamine) or their isotype controls (b). White arrowheads show CD11b+ Mo/Mph (a), and white arrows show CD11b+ cells in contiguity with iC3b (c). Scale bar = 20 µm. n = 3.

 
In situ hybridization studies for TNF-{alpha}

In situ hybridization with TNF-{alpha} antisense riboprobes was also performed in UV-exposed skin to evaluate the in vivo localization of TNF-{alpha} production (n = 3). In control unirradiated skin, we detected only a few TNF-{alpha}+ cells (Fig. 3Goa), whereas TNF-{alpha} mRNA was markedly induced in UV-exposed skin taken at 72 h (Fig. 3Goc). Many cells expressing TNF-{alpha} in the epidermis along the DEJ were keratinocytes with intracytoplasmic bridging (Fig. 3Goc, black arrows). Other TNF-{alpha}+ cells were seen around the vessels in the papillary dermis (Fig. 3Goc, black arrowheads). UV-exposed skin treated with the sense riboprobe (negative control) was negative (Fig. 3Gob).



View larger version (87K):
[in this window]
[in a new window]
 
FIGURE 3. TNF-{alpha} mRNA is present in UV-exposed skin. In situ hybridization was performed in normal skin (a) and skin taken 72 h after UV exposure (c) with digoxigenin-labeled antisense riboprobes for TNF-{alpha} and counterstained by nuclear fast red. A sense riboprobe was used at the same time in skin taken 72 h after UV exposure (b), showing no staining. Black arrows show TNF-{alpha} mRNA+ keratinocytes, and black arrowheads show TNF-{alpha} mRNA+ infiltrating cells in the dermis (c). Scale bar = 20 µm. n = 3.

 
Binding of iC3b to ß2 integrin on monocytes induces IL-10 mRNA synthesis and protein secretion

We hypothesized that binding of iC3b to ß2 integrin on infiltrating Mo/Mph following UV exposure might be involved in the regulation of IL-10 cytokine production. To elucidate the effect of iC3b binding on monocyte cytokine production, monocytes were purified from peripheral blood by negative selection, and EAiC3b were prepared. The presence of CD11b on monocytes and iC3b on the cell surface of erythrocytes was verified by flow cytometry (data not shown). Highly purified monocytes (>90%) were incubated with medium alone, EA, or EAiC3b for 20 h. Total monocyte RNA was then extracted, and RT-PCR for IL-10 was performed (Fig. 4GoA). Monocyte IL-10 mRNA was undetectable when incubated with medium alone or EA (Fig. 4GoA, lanes 1 and 3), whereas incubation with EAiC3b resulted in IL-10 mRNA induction (Fig. 4GoA,lane 5). The secretion of IL-10 protein in the supernatant under identical conditions was measured by ELISA (Fig. 4GoB). The production of IL-10 was minimal in medium alone (<10 pg/ml) or when incubated with EA, whereas IL-10 was significantly increased when stimulated with EAiC3b in comparison with medium alone or EA (Fig. 4GoB; p < 0.01; n = 9). It is unlikely that IL-10 production induced by EAiC3b, but not EA, was caused by a low amount of endotoxin contamination because we used the same buffer, IgM, erythrocytes, etc. to prepare EA and EAiC3b. The only difference was the inclusion of C5-deficient serum and 1% human serum. Nevertheless, we examined whether C5-deficient serum and 1% human serum could stimulate IL-10 production. Neither stimulated IL-10 production upon incubation with fresh human monocytes under conditions identical with those used for the iC3b experiments (data not shown).



View larger version (28K):
[in this window]
[in a new window]
 
FIGURE 4. Binding of iC3b induces monocyte IL-10 mRNA synthesis and protein production. Monocytes were incubated with medium alone (M), EA, or EAiC3b (erythrocyte:monocyte ratio of 25:1) with or without TNF-{alpha} (50 ng/ml). A, After 20 h, total RNA was extracted and was used to carry out RT-PCR using primers for IL-10 and ß-actin. Results are representative of three separate experiments, each of which showed similar results. B, Alternatively, after 20 h, IL-10 levels in supernatants were determined by ELISA. Results are expressed as the mean ± SEM of nine subjects (without TNF-{alpha}) and six subjects (with TNF-{alpha}). *, p < 0.05 vs EAiC3b without TNF-{alpha}, and M or EA with TNF-{alpha}; **, p < 0.01 vs M or EA without TNF-{alpha} (determined by Student’s t test).

 
To prove more definitively that the interaction between iC3b and CD11b is the signal that induces monocyte IL-10 production, monocytes were incubated with 25 µg/ml M1/70 Ab, which is reported to block iC3b binding to CD11b (40), for 1 h before incubation with EAiC3b. Whereas monocytes incubated with EAiC3b under identical conditions with an IgG2b isotype control Ab induced significant IL-10 production, monocytes incubated with the M1/70 CD11b blocking Ab demonstrated complete abrogation of IL-10 synthesis. These results suggest that the iC3b signal is transduced via CD11b. These latter data also rule out endotoxin contamination of the iC3b preparation (Table IGo).


View this table:
[in this window]
[in a new window]
 
Table I. Anti-Mac1 blocks IL-10 induction by iC3b1

 
IL-10 production of monocytes by iC3b is enhanced by stimulation with TNF-{alpha}

After UV exposure, TNF-{alpha} mRNA is induced in vivo in the same microanatomic areas as iC3b deposition and Mo/Mph infiltration, as shown in Fig. 3Go. To further model the in vivo conditions in UV-exposed skin, purified monocytes were incubated with medium alone, EA, or EAiC3b in combination with 50 µg/ml TNF-{alpha}. The appropriate concentration of TNF-{alpha} was determined in preliminary experiments (data not shown). After 20-h incubation, RT-PCR and ELISA were performed. Although TNF-{alpha} alone induced small amounts of IL-10 mRNA (Fig. 4GoA, lanes 2 and 4), the combination of TNF-{alpha} with iC3b resulted in potent induction of IL-10 mRNA (Fig. 4GoA, lane 6). Similarly, combined exposure to both TNF-{alpha} and iC3b resulted in a significant increase in IL-10 protein secretion relative to that caused by EAiC3b alone, TNF-{alpha} alone, or TNF-{alpha} plus EA (Fig. 4GoB; p < 0.05).

Binding of iC3b to ß2 integrin on monocytes down-regulates IL-12 mRNA synthesis and protein secretion

To evaluate the effect of iC3b on monocyte IL-12 production, purified monocytes were incubated with medium alone, EA, or EAiC3b in combination with SAC (0.001%) as a stimulator for IL-12 for 20 h (IL-12 was not detectable in resting monocytes without any stimulation). Total monocyte RNA was then extracted, and RT-PCR was performed for IL-12 p40. Although IL-12 p40 mRNA was not detectable when monocytes were incubated with medium alone, incubation with SAC briskly stimulated IL-12 mRNA synthesis (Fig. 5GoA, lanes 1 and 2). This induction of IL-12 was down-regulated when incubated with EAiC3b (Fig. 5GoA, lane 4), but not with EA (Fig. 5GoA, lane 3). ELISA analysis of protein secretion into the supernatant under identical conditions confirmed that reduced mRNA production by iC3b resulted in significantly reduced IL-12 p70 formation (Fig. 5GoB). As with mRNA for IL-12 p40, the production of IL-12 p70 was not detected in medium alone, but was up-regulated when incubated with SAC. This production was significantly inhibited by incubation with EAiC3b compared with medium or EA in combination with SAC (Fig. 5GoB; p < 0.01; n = 6).



View larger version (29K):
[in this window]
[in a new window]
 
FIGURE 5. Binding of iC3b down-regulates monocyte IL-12 p40 mRNA synthesis and protein production. Monocytes were incubated with medium alone (M), EA, or EAiC3b (erythrocyte:monocyte ratio of 25:1). SAC (0.001%) was used as the stimulator for IL-12 production. A, After 20 h, total RNA was extracted and was used to carry out RT-PCR using primers for the p40 subunit of IL-12 and ß-actin. Results are representative of three separate experiments, each of which showed similar results. B, Alternatively, after 20 h, IL-12 p70 levels in supernatants were determined by ELISA. Results are expressed as the mean ± SEM of six subjects. **, p < 0.01 vs M or EA with SAC (determined by Student’s t test).

 
To determine whether TNF-{alpha} regulates IL-12 as well as IL-10 in this model, TNF-{alpha} was used to stimulate monocytes in combination with SAC. However, addition of TNF-{alpha} did not modify IL-12 mRNA synthesis (data not shown), and protein secretion was not significantly altered, although it was slightly decreased by TNF-{alpha} (Table IIGo).


View this table:
[in this window]
[in a new window]
 
Table II. IL-12 p70 protein secretion1 by binding of iC3b on blood human monocytes stimulated with SAC in combination with TNF-{alpha}

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
These studies demonstrate a novel contextual signaling mechanism in which Mo/Mph are induced into an IL-10high/IL-12low activation/differentiation state by iC3b in the context of coincident TNF-{alpha}. This system models the UV-influenced cutaneous microenvironment having similar cytokine and iC3b patterns in combination with monocyte infiltration. We have previously shown that CD11b+ Mo/Mph infiltrate UV-exposed skin (15, 16), and that they are implicated in UV-induced immunosuppression and tolerance induction (17, 18, 19). Furthermore, depletion of iC3b (a ligand for CD11b) or blockade of CD11b itself in UV-exposed skin is capable of negating these effects of UV in mice (18, 24). In addition, our previous findings indicate that CD11b+ Mo/Mph are the main source of IL-10-secreted protein in UV-exposed human skin compared with keratinocytes (20, 21). Conversely, Langerhans cells, which produce IL-12 (41), are depleted in the epidermis after UV irradiation, as are their dendritic Ag-presenting counterparts in the dermis (42, 43, 44). This is associated with loss of IL-12-producing cells in human dermis after UV (21). Restoration of immune-sensitizing potential after UV occurs when rIL-12 is provided (13, 14), as occurs with blockade of CD11b and depletion of iC3b. These observations led to the hypothesis that the ligand for CD11b may be induced in UV-irradiated skin and that signaling through ß2 integrin is partially responsible for the regulation of cytokine production (both IL-10 and IL-12) by Mo/Mph.

We performed immunofluorescence studies to determine whether iC3b deposits are present in UV-exposed human skin. As hypothesized, UV-exposed skin clearly showed increased iC3b deposits at the DEJ relative to normal skin; iC3b+ keratinocytes in the epidermis also appeared (Fig. 1Go). Moreover, double staining revealed that infiltrating CD11b+ Mo/Mph appeared to be juxtaposed to these deposits at the DEJ before they migrated into the epidermis where they were also found adjacent to iC3b+ keratinocytes (Fig. 2Go). These data suggested that a major ligand for CD11b, iC3b, was abundant in UV-irradiated human skin.

Another key element implicated in UV-induced immunosuppression is TNF-{alpha}. (32, 33). It is well known that TNF-{alpha} is produced in UV-exposed skin by keratinocytes and mast cells (34, 35). TNF-{alpha} has also been reported to induce monocyte IL-10 (36). However, the in vivo localization of TNF-{alpha} mRNA in UV-exposed human skin has not been explored, and it is not clear whether TNF-{alpha} might be influencing blood monocytic cells as they enter, migrate, and differentiate in the dermis after UV injury. We performed in situ hybridization for TNF-{alpha} and found that TNF-{alpha} mRNA was indeed present in the papillary dermis and basal epidermis in UV-exposed skin (Fig. 3Go), indicating that TNF-{alpha} was being produced in the same microanatomic area that contained iC3b deposits and infiltrating CD11b+ Mo/Mph.

To address how binding of iC3b to ß2 integrin alters cytokine production in the presence of TNF-{alpha}, we used resting monocytes from peripheral blood rather than human skin tissue in our experimental model, because tissue Mo/Mph have presumably already been activated by many factors in skin. After the purification of monocytes, monocytes were incubated with iC3b. The data clearly demonstrate the novel finding that iC3b induces IL-10 mRNA and protein. In addition, IL-10 induction was markedly enhanced by contextual exposure to TNF-{alpha} (Fig. 4Go). To prove more definitively that IL-10 production is due to the interaction between iC3b and CD11b, CD11b on monocytes was blocked by M1/70 Ab. This abrogated IL-10 production by EAiC3b, indicating that iC3b binding to CD11b plays an important role in cytokine production (Table IGo). By contrast, the reciprocal immunomodulatory cytokine, IL-12, was inhibited at the mRNA and protein levels by iC3b (Fig. 5Go), confirming the ability of iC3b to inhibit IL-12 (30, 31). Concomitant TNF-{alpha} exposure did not prevent inhibition of IL-12. Thus, at the same time that iC3b induces IL-10 in freshly immigrated monocytes, it may restrain IL-12 production in vivo.

Although it is not entirely clear how UV exposure induces immunosuppression, most of the evidence suggests that decreased IL-12 (12, 13, 14), increased IL-10 (3, 4, 5, 6, 7, 8, 9, 10) and TNF-{alpha} (32, 33) produced by UV exposure have an important role. Our findings now provide a novel model of how UV irradiation preferentially induces inflammatory injury and immunosuppression. Following UV exposure in vivo, there is created in skin a sequentially evolving milieu of soluble signals, such as iC3b and TNF-{alpha}, which drives newly immigrating Mo/Mph toward IL-10high/IL-12low differentiation. Therefore, at the time of Ag presentation, Mo/Mph-derived IL-10 in an IL-12-inhibited environment may modulate APC function so that proliferation of T cells that mediate immune response is inhibited, contributing to UV-induced immunosuppression.

Our results differ from recently published work that showed that CR3 signaling had little effect on IL-10 production by monocytes (30, 31). This may be because we measured induction of IL-10 after stimulation by iC3b itself, rather than concomitantly with LPS, LPS plus IFN-{gamma}, or SAC plus IFN-{gamma}, which may drown out the effect of iC3b. Our model may reflect more reliably the in vivo conditions that we believe to be induced in the UV milieu.

In conclusion, our studies demonstrate a novel mechanism of IL-10 up-regulation and IL-12 down-regulation via iC3b in combination with TNF-{alpha}, which may be responsible for Mo/Mph differentiation and activation as they infiltrate UV-exposed skin and may be relevant to immunosuppression following UV exposure.


    Acknowledgments
 
We greatly appreciated the expert technical assistance of Erica Wetzler.


    Footnotes
 
1 This work was supported in part by grants from the National Institutes of Health (National Institute of Allergy and Infectious Diseases, AI41766; to K.D.C.); the Veterans Administration Medical Research Service (to K.D.C.); the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Center (AR39750; to K.D.C. and A.C.G.); the National Institutes of Health (AI22687; to M.B.); the Dermatology Foundation: Mary Kay Cosmetics Grant (to A.C.G.); Pfizer Pharmaceuticals Group, New York (to K.K.); and an Ohio Reagents Pilot Study Grant (to A.C.G.). Back

2 Address correspondence and reprint requests to Dr. Kefei Kang, Department of Dermatology, Case Western Reserve University and University Hospitals of Cleveland, 11100 Euclid Ave., Cleveland, OH 44106. E-mail address: Back

3 Abbreviations used in this paper: Mo/Mph, monocytic/macrophagic cells; DEJ, dermal-epidermal junction; EA, immunoglobulin M-coated sheep erythrocytes; EAiC3b, immunoglobulin M- plus iC3b-coated sheep erythrocytes; SAC, Staphylococcus aureus cells. Back

Received for publication April 17, 1998. Accepted for publication July 23, 1998.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Yoshikawa, T., V. Rae, W. Bruins-Slot, J.-W. Van den Berg, J. R. Taylor, J. W. Streilein. 1990. Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J. Invest. Dermatol. 95:530.[Medline]
  2. Streilein, J. W., J. R. Taylor, V. Vincek, I. Kurimoto, T. Shimizu, C. Tie, C. Golomb. 1994. Immune surveillance and sunlight-induced skin cancer. Immunol. Today 15:174.[Medline]
  3. Enk, A. H., J. Saloga, D. Becker, M. Mohamadzadeh, J. Knop. 1994. Induction of hapten-specific tolerance by interleukin 10 in vivo. J. Exp. Med. 179:1397.[Abstract/Free Full Text]
  4. Kondo, S., R. C. McKenzie, D. N. Sauder. 1994. Interleukin-10 inhibits the elicitation phase of allergic contact hypersensitivity. J. Invest. Dermatol. 103:811.[Medline]
  5. Schwarz, A., S. Grabbe, H. Riemann, Y. Aragane, M. Simon, S. Manon, S. Andrade, T. A. Luger, A. Zlotnik, T. Schwarz. 1994. In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. J. Invest. Dermatol. 103:211.[Medline]
  6. Rivas, J. M., S. E. Ullrich. 1992. Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes: an essential role for keratinocyte-derived IL-10. J. Immunol. 149:3865.[Abstract]
  7. Enk, A. H., V. L. Angeloni, M. C. Udey, S. I. Katz. 1993. Inhibition of Langerhans cell antigen-presenting function by IL-10: a role for IL-10 in induction of tolerance. J. Immunol. 151:2390.[Abstract]
  8. Ullrich, S. E.. 1994. Mechanism involved in the systemic suppression of antigen-presenting cell function by UV irradiation: keratinocyte-derived IL-10 modulates antigen-presenting cell function of splenic adherent cells. J. Immunol. 152:3410.[Abstract]
  9. Ding, L., P. S. Linsley, L.-Y. Huang, R. N. Germain, E. M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151:1224.[Abstract]
  10. Ozawa, H., S. Aiba, S. Nakagawa, H. Tagami. 1990. Interferon-{gamma} and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression. Eur. J. Immunol. 26:648.
  11. D’Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, G. Trinchieri. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon {gamma}-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041.[Abstract/Free Full Text]
  12. Riemann, H., A. Schwarz, S. Grabbe, Y. Aragane, T. A. Luger, M. Wysocka, M. Kubin, G. Trinchieri, T. Schwarz. 1996. Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance. J. Immunol. 156:1799.[Abstract]
  13. Schmitt, D. A., L. Owen-Schaub, S. E. Ullrich. 1995. Effect of IL-12 on immune suppression and suppressor cell induction by ultraviolet radiation. J. Immunol. 154:5114.[Abstract]
  14. Schwarz, A., S. Grabbe, Y. Aragane, K. Sandkuhl, H. Riemann, T. A. Luger, M. Kubin, G. Trinchieri, T. Schwarz. 1996. Interleukin-12 prevents ultraviolet B-induced local immunosuppression and overcomes UVB-induced tolerance. J. Invest. Dermatol. 106:1187.[Medline]
  15. Cooper, K. D., N. Duraiswamy, C. Hammerberg, E. Allen, C. Kimbrough-Green, W. Dillon, D. Thomas. 1993. Neutrophils, differentiated macrophages, and monocyte/macrophage antigen presenting cells infiltrate murine epidermis after UV injury. J. Invest. Dermatol. 101:155.[Medline]
  16. Duraiswamy, N., Y. Tse, C. Hammerberg, S. Kang, K. D. Cooper. 1994. Distinction of class II MHC+ Langerhans cell-like interstitial dendritic antigen-presenting cells in murine dermis from dermal macrophages. J. Invest. Dermatol. 103:678.[Medline]
  17. Hammerberg, C., N. Duraiswamy, K. D. Cooper. 1994. Active induction of unresponsiveness (tolerance) to DNFB by in vivo ultraviolet-exposed epidermal cells is dependent upon infiltrating class II MHC+ CD11b(bright) monocytic/macrophagic cells. J. Immunol. 153:4915.[Abstract]
  18. Hammerberg, C., N. Duraiswamy, K. D. Cooper. 1996. Reversal of immunosuppression inducible through ultraviolet-exposed skin by in vivo anti-CD11b treatment. J. Immunol. 157:5254.[Abstract]
  19. Hammerberg, C., N. Duraiswamy, K. D. Cooper. 1996. Temporal correlation between UV radiation locally-inducible tolerance and the sequential appearance of dermal, then epidermal, class II MHC+ CD11b+ monocytic/macrophagic cells. J. Invest. Dermatol. 107:755.[Medline]
  20. Kang, K., C. Hammerberg, L. Meunier, K. D. Cooper. 1994. CD11b+ macrophages that infiltrate human epidermis after in vivo ultraviolet exposure potently produce IL-10 and represent the major secretory source of epidermal IL-10 protein. J. Immunol. 153:5256.[Abstract]
  21. Kang, K., A. C. Gilliam, G. Chen, E. Tootell, K. D. Cooper. 1998. In human skin, UVB initiates early induction of IL-10 over IL-12 preferentially in the expanding dermal monocytic/macrophagic population. J. Invest. Dermatol. 110:31.
  22. Diamond, M. S., J. Garcia-Aguilar, J. K. Bickford, A. L. Corbi, T. A. Springer. 1993. The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J. Cell Biol. 120:1031.[Abstract/Free Full Text]
  23. Ueda, T., P. Rieu, J. Brayer, M. A. Arnaout. 1994. Identification of the complement iC3b binding site in the ß2 integrin CR3 (CD11b/CD18). Proc. Natl. Acad. Sci. USA 91:10680.[Abstract/Free Full Text]
  24. Hammerberg, C., S. K. Katiyar, M. C. Carroll, K. D. Cooper. 1998. Activated complement 3(C3) is required for UV induction of immunosuppression and antigenic tolerance. J. Exp. Med. 187:1133.[Abstract/Free Full Text]
  25. Basset-Seguin, N., S. W. Caughman, K. B. Yancey. 1990. A-431 cells and human keratinocytes synthesize and secrete the third component of complement. J. Invest. Dermatol. 95:621.[Medline]
  26. Dovezenski, N., R. Billetta, I. Gigli. 1992. Expression and localization of proteins of the complement system in human skin. J. Clin. Invest. 90:2000.
  27. Basset-Seguin, N., M. Dersookian, K. Cehrs, K. B. Yancey. 1988. C3d, g is present in normal human epidermal basement membrane. J. Immunol. 141:1273.[Abstract]
  28. Basset-Seguin, N., M. Porneuf, O. Dereure, V. Mils, A. Tesnieres, K. B. Yancey, J.-J. Guilhou. 1993. C3d, g deposits in inflammatory skin diseases: use of psoriatic skin as a model of cutaneous inflammation. J. Invest. Dermatol. 101:827.[Medline]
  29. Rauterberg, A., E. G. Jung, E. W. Rauterberg. 1993. Complement deposits in epidermal cells after ultraviolet B exposure. Photodermatol. Photoimmunol. Photomed. 9:135.[Medline]
  30. Sutterwala, F. S., G. J. Noel, R. Clynes, D. M. Mosser. 1997. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J. Exp. Med. 185:1977.[Abstract/Free Full Text]
  31. Marth, T., B. L. Kelsall. 1997. Regulation of interleukin-12 by complement receptor 3 signaling. J. Exp. Med. 185:1987.[Abstract/Free Full Text]
  32. Yoshikawa, T., J. W. Streilein. 1990. Tumor necrosis factor-{alpha} and ultraviolet B light have similar effects on contact hypersensitivity in mice. Reg. Immunol. 3:139.[Medline]
  33. Moodycliffe, A. M., I. Kimber, M. Norval. 1994. Role of tumour necrosis factor-{alpha} in ultraviolet B light-induced dendritic cell migration and suppression of contact hypersensitivity. Immunology 81:79.[Medline]
  34. Kock, A., T. Schwarz, R. Kirnbauer, A. Urbanski, P. Perry, J. C. Ansel, T. A. Luger. 1990. Human keratinocytes are a source for tumor necrosis factor {alpha}: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J. Exp. Med. 172:1609.[Abstract/Free Full Text]
  35. Walsh, L. J.. 1995. Ultraviolet B irradiation of skin induces mast cell degranulation and release of tumor necrosis factor-{alpha}. Immunol. Cell Biol. 73:226.[Medline]
  36. Wanidworanun, C., W. Strober. 1993. Predominant role of tumor necrosis factor-{alpha} in human monocyte IL-10 synthesis. J. Immunol. 151:6853.[Abstract]
  37. Wilcox, J. N.. 1993. Fundamental principles of in situ hybridization. J. Histochem. Cytochem. 41:1725.[Abstract]
  38. Ross, G. D.. 1980. Analysis of the different types of leukocyte membrane complement receptors and their interaction with the complement system. J. Immunol. Methods. 37:197.[Medline]
  39. Kusunoki, T., E. Hailman, T. S.-C. Juan, H. S. Lichenstein, S. D. Wright. 1995. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. J. Exp. Med. 182:1673.[Abstract/Free Full Text]
  40. Beller, D. I., T. A. Springer, R. D. Schreiber. 1982. Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor. J. Exp. Med. 156:1000.[Abstract/Free Full Text]
  41. Kang, K., M. Kubin, K. D. Cooper, S. R. Lessin, G. Trinchieri, A. H. Rook. 1996. IL-12 synthesis by human Langerhans cells. J. Immunol. 156:1402.[Abstract]
  42. Meunier, L., A. Gonzalez-Ramos, K. D. Cooper. 1993. Heterogeneous populations of class II MHC+ cells in human dermal cell suspensions: identification of a small subset responsible for potent dermal antigen-presenting cell activity with features analogous to Langerhans cells. J. Immunol. 151:4067.[Abstract]
  43. Meunier, L., Z. Bata-Csorgo, K. D. Cooper. 1995. In human dermis, UV induces expansion of a CD36+CD11b+CD1- macrophage subset by infiltration and proliferation; CD1+ Langerhans-like dendritic antigen-presenting cells are concomitantly depleted. J. Invest. Dermatol. 105:782.[Medline]
  44. Gilliam, A. C., I. B. Kremer, Y. Yoshida, S. R. Stevens, E. Tootell, M. B. M. Teunissen, C. Hammerberg, K. D. Cooper. 1998. The human hair follicle: a reservoir of CD40+B7-deficient Langerhans cells which repopulate epidermis after UVB exposure. J. Invest. Dermatol. 110:422.[Medline]



This article has been cited by other articles:


Home page
IOVSHome page
P. Jha, J.-H. Sohn, Q. Xu, H. Nishihori, Y. Wang, S. Nishihori, B. Manickam, H. J. Kaplan, P. S. Bora, and N. S. Bora
The complement system plays a critical role in the development of experimental autoimmune anterior uveitis.
Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 1030 - 1038.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. E. Morelli, J. P. Rubin, G. Erdos, O. A. Tkacheva, A. R. Mathers, A. F. Zahorchak, A. W. Thomson, L. D. Falo Jr., and A. T. Larregina
CD4+ T Cell Responses Elicited by Different Subsets of Human Skin Migratory Dendritic Cells
J. Immunol., December 15, 2005; 175(12): 7905 - 7915.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
N. Tang, L. Liu, K. Kang, P. K. Mukherjee, M. Takahara, G. Chen, T. S. McCormick, K. D. Cooper, and M. Ghannoum
Inhibition of Monocytic Interleukin-12 Production by Candida albicans via Selective Activation of ERK Mitogen-Activated Protein Kinase
Infect. Immun., May 1, 2004; 72(5): 2513 - 2520.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. E. Morelli, A. T. Larregina, W. J. Shufesky, A. F. Zahorchak, A. J. Logar, G. D. Papworth, Z. Wang, S. C. Watkins, L. D. Falo Jr, and A. W. Thomson
Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production
Blood, January 15, 2003; 101(2): 611 - 620.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. Liu, K. Kang, M. Takahara, K. D. Cooper, and M. A. Ghannoum
Hyphae and Yeasts of Candida albicans Differentially Regulate Interleukin-12 Production by Human Blood Monocytes: Inhibitory Role of C. albicans Germination
Infect. Immun., July 1, 2001; 69(7): 4695 - 4697.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. S. Gerber and D. M. Mosser
Reversing Lipopolysaccharide Toxicity by Ligating the Macrophage Fc{{gamma}} Receptors
J. Immunol., June 1, 2001; 166(11): 6861 - 6868.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Xiong, K. Kang, L. Liu, Y. Yoshida, K. D. Cooper, and M. A. Ghannoum
Candida albicans and Candida krusei Differentially Induce Human Blood Mononuclear Cell Interleukin-12 and Gamma Interferon Production
Infect. Immun., May 1, 2000; 68(5): 2464 - 2469.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshida, Y.
Right arrow Articles by Cooper, K. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshida, Y.
Right arrow Articles by Cooper, K. D.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS